<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04210206</url>
  </required_header>
  <id_info>
    <org_study_id>CoFu-PKU</org_study_id>
    <nct_id>NCT04210206</nct_id>
  </id_info>
  <brief_title>Short-term Effects of Good Metabolic Control on Cognitive Function, Wellbeing, and Metabolic Parameters in Adult Patients With Phenylketonuria</brief_title>
  <official_title>Kurzfristiger Einfluss Einer Guten Stoffwechseleinstellung Auf Kognitive Funktion, Wohlbefinden Und Stoffwechselparameter Bei Erwachsenen Patienten Mit Phenylketonurie (Short-term Effects of Good Metabolic Control on Cognitive Function, Wellbeing, and Metabolic Parameters in Adult Patients With Phenylketonuria)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klaus Parhofer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate if in adult patients with phenylketonuria (PKU) without
      strict metabolic control during the last 12 months, strict metabolic control for 8 weeks
      results in an improvement of cognitive function.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spatial working memory strategy index</measure>
    <time_frame>8 weeks</time_frame>
    <description>cognitive function; scores range from 4 to 28, with lower scores representing better outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reaction time</measure>
    <time_frame>8 weeks</time_frame>
    <description>cognitive function; milliseconds, with faster times representing better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Paired Associates Learning</measure>
    <time_frame>8 weeks</time_frame>
    <description>cognitive function; scores range from 0 to 70, with lower scores indicating better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multitasking Test</measure>
    <time_frame>8 weeks</time_frame>
    <description>cognitive function; scores range from 0 to 279, with lower scores indicating better outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Phenylketonurias</condition>
  <arm_group>
    <arm_group_label>Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PHE-diet</intervention_name>
    <description>phenylalanine-restricted diet with phenylalanine free supplements for 8 weeks</description>
    <arm_group_label>Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women with classical PKU

          -  Age ≥ 18 years

          -  Good metabolic control during childhood (at least until 12 years of age)

          -  Plasma Phe levels ≥ 15 mg/dl for ≥ 1 year

          -  Written informed consent prior to study participation

        Exclusion Criteria:

          -  Reduced cognitive function (unability to perform test battery)

          -  Drug and or alcohol abuse

          -  Treatment with BH4

          -  Treatment with drugs known to affect cognitive function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Klaus G Parhofer, MD</last_name>
    <phone>+4989440073010</phone>
    <email>klaus.parhofer@med.uni-muenchen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Munich</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus G Parhofer, MD</last_name>
      <phone>+49-89-7095</phone>
      <phone_ext>3010</phone_ext>
      <email>klaus.parhofer@med.uni-muenchen.de</email>
    </contact>
    <contact_backup>
      <last_name>Elisa Waldmann, MD</last_name>
      <phone>+49-89-7095</phone>
      <phone_ext>2262</phone_ext>
      <email>elisa.waldmann@med.uni-muenchen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 19, 2019</study_first_submitted>
  <study_first_submitted_qc>December 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2019</study_first_posted>
  <last_update_submitted>December 20, 2019</last_update_submitted>
  <last_update_submitted_qc>December 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Klaus Parhofer</investigator_full_name>
    <investigator_title>Professor of Endocrinology and Metabolism</investigator_title>
  </responsible_party>
  <keyword>cognitive function adults</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylketonurias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

